Abstract
Ticagrelor (BRILINTA (R)) is a very commonly used oral antiplalelet agent in acute coronary syndrome and after percutaneous coronary intervention (PCI......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
